Literature DB >> 2258059

Use of a selectable reporter for the isolation of mammalian regulatory genes.

A E Morris1, Y J Jiang, R E McChesney, A E Jackson, C Bancroft, L A Chasin.   

Abstract

A general method is described for isolating the genes encoding differentiation-specific activators of transcription using genetic selection. Employing regulation of the prolactin encoding gene (PRL) as a model, we have shown that the hamster dihydrofolate reductase-encoding gene (dhfr) is an effective dominant selectable reporter in this methodology. The dhfr coding region was ligated to the rat PRL promoter, and the resultant construct was stably transfected into DHFR- Chinese hamster ovary (CHO) cells, where it had little or no activity. Transfection of these cells with plasmid DNA, containing the coding region of a pituitary-specific transcription factor (Pit-1/GHF-1) in a eukaryotic expression vector, resulted in transfectants in which activation of the chimeric construct, pPRLdhfr, had occurred, enabling these cells to be selected on the basis of their DHFR+ phenotype. Our results suggest that this strategy could be used to isolate unknown genes that regulate a variety of differentiated functions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258059     DOI: 10.1016/0378-1119(90)90400-l

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  An alternatively spliced Pit-1 isoform altered in its ability to trans-activate.

Authors:  A E Morris; B Kloss; R E McChesney; C Bancroft; L A Chasin
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

2.  Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.

Authors:  C Panousis; V M Rayzman; T G Johns; C Renner; Z Liu; G Cartwright; F-T Lee; D Wang; H Gan; D Cao; A Kypridis; F E Smyth; M W Brechbiel; A W Burgess; L J Old; A M Scott
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.